Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ramkhamhaeng Hospital PCLBKK:RAM -0.56%77 EV-to-EBITDA is 9.46 as of Jul. 15, 2026, which is 49% below its 10-year median of 18.52. GuruFocus rates BKK:RAM with a GF Score™ of 77/100 and a GF Value™ of ฿45.41 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 507 Healthcare Providers & Services companies, Ramkhamhaeng Hospital PCL ranks better than 58.38% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Ramkhamhaeng Hospital PCL's enterprise value is ฿54,877 Mil.
Ramkhamhaeng Hospital PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ฿5,800 Mil. Therefore, Ramkhamhaeng Hospital PCL's EV-to-EBITDA for today is 9.46.
The historical rank and industry rank for Ramkhamhaeng Hospital PCL's EV-to-EBITDA or its related term are showing as below:
BKK:RAM'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.68 Med: 18.52 Max: 29.85
Current: 9.46
During the past 13 years, the highest EV-to-EBITDA of Ramkhamhaeng Hospital PCL was 29.85. The lowest was 7.68. And the median was 18.52.
BKK:RAM's EV-to-EBITDA is ranked better than 58.38% of 507
companies
in the Healthcare Providers & Services industry
Industry Median: 10.89
vs BKK:RAM: 9.46
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Ramkhamhaeng Hospital PCL's PE Ratio (TTM) for today is calculated as:
Ramkhamhaeng Hospital PCL's share price for today is ฿17.90.
Ramkhamhaeng Hospital PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿2.240.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Ramkhamhaeng Hospital PCL's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ramkhamhaeng Hospital PCL EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ramkhamhaeng Hospital PCL's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Ramkhamhaeng Hospital PCL's EV-to-EBITDA falls into.
Ramkhamhaeng Hospital PCL's current Enterprise Value is ฿54,877 Mil.
Ramkhamhaeng Hospital PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿5,800 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ramkhamhaeng Hospital PCL (BKK:RAM) has a EV-to-EBITDA of 9.46 as of Jul. 15, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Ramkhamhaeng Hospital PCL. This is 49% below median its historical median of 18.52. Over the past decade, Ramkhamhaeng Hospital PCL's EV-to-EBITDA has ranged from 7.68 to 29.85. According to the industry distribution chart, Ramkhamhaeng Hospital PCL ranks #211 out of 507 companies in the Healthcare Providers & Services industry, placing it in the top 41.6%.
Is Ramkhamhaeng Hospital PCL's EV-to-EBITDA too high?
Ramkhamhaeng Hospital PCL's current EV-to-EBITDA of 9.46 is 49% below median its 10-year median of 18.52. Over the past 10 years, this metric has ranged from a low of 7.68 to a high of 29.85. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.89. Ramkhamhaeng Hospital PCL's value of 9.46 is 13.1% below this industry median. Based on the distribution chart, Ramkhamhaeng Hospital PCL ranks #211 out of 507 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ramkhamhaeng Hospital PCL has a GF Score™ of 77/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ramkhamhaeng Hospital PCL's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ramkhamhaeng Hospital PCL ranks #211 out of 507 companies for EV-to-EBITDA. This puts Ramkhamhaeng Hospital PCL in the upper half of its industry. The industry median EV-to-EBITDA is 10.89. Ramkhamhaeng Hospital PCL's value of 9.46 is 13.1% below this benchmark. Historically, Ramkhamhaeng Hospital PCL's own EV-to-EBITDA has ranged from 7.68 to 29.85 over the past decade. While the company's 10-year median is 18.52 vs. the industry median of 10.89, Ramkhamhaeng Hospital PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.89, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ramkhamhaeng Hospital PCL's current EV-to-EBITDA of 9.46 is 13.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Ramkhamhaeng Hospital PCL. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ramkhamhaeng Hospital PCL's current EV-to-EBITDA is 9.46, which is 49% below median its own 10-year median of 18.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramkhamhaeng Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, Ramkhamhaeng Hospital PCL (BKK:RAM) is currently considered Possible Value Trap. The stock's GF Value™ is ฿45.41, compared to a current price of ฿17.90 — trading 60.6% below its estimated fair value. The current EV-to-EBITDA is 9.46, which is 49% below median its 10-year median of 18.52 and 13.1% below the Healthcare Providers & Services industry median of 10.89. Ramkhamhaeng Hospital PCL's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Ramkhamhaeng Hospital PCL (BKK:RAM), the current EV-to-EBITDA is 9.46 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramkhamhaeng Hospital PCL (BKK:RAM) Overvalued in 2026?
Based on GuruFocus' analysis, Ramkhamhaeng Hospital PCL stock appears to be undervalued.
The current stock price of ฿17.90 is trading 60.6% below its estimated GF Value™ of ฿45.41.
GuruFocus considers Ramkhamhaeng Hospital PCL to be Possible Value Trap.
Key valuation signals for BKK:RAM:
EV-to-EBITDA: 9.46 (49% below median its 10-year median of 18.52)
GF Value™: ฿45.41 vs. price of ฿17.90 (60.6% below fair value)
Industry Position: 13.1% below the Healthcare Providers & Services median (#211 of 507)
No single metric tells the full story. See the BKK:RAM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramkhamhaeng Hospital PCL business activities are hospital and businesses that support medical care. The company provides medical treatment for all types of diseases by physicians and medical professionals in all specialties. Its medical services include the 24-hour Heart Center, RAM Pituitary Center for laparoscopic surgery for pituitary tumors, Neurology & Neurosurgery Center, and specialized medical centers such as Eye Clinic, Ear, Nose and Throat Clinic, Gastroenterology Clinic, Obstetrics and Gynecology Clinic, and Diabetes Clinic. The company operates through two segments: Hospital, which includes General Hospital and Hospital in Social Security and generates the maximum revenue; and Others, which includes sale of medical equipment and instruments. Its operations are in Thailand.
77GF Score
Get the complete analysis for BKK:RAM
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:RAM has been successfully added to your 
